Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

被引:410
|
作者
Takahashi, Yoshihisa [1 ]
Soejima, Yurie [1 ]
Fukusato, Toshio [1 ]
机构
[1] Teikyo Univ, Sch Med, Dept Pathol, Itabashi Ku, Tokyo 1738605, Japan
关键词
Animal model; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Metabolic syndrome; Histopathology; ACTIVATED-RECEPTOR-ALPHA; CHOLINE-DEFICIENT DIET; METHIONINE ADENOSYLTRANSFERASE 1A; FRUCTOSE-ENRICHED DIETS; INSULIN-RESISTANCE; METABOLIC SYNDROME; DB/DB MICE; HEPATIC INFLAMMATION; OXIDATIVE STRESS; NATURAL-HISTORY;
D O I
10.3748/wjg.v18.i19.2300
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nonalcoholic fatty liver disease (NAFLD) is a condition in which excess fat accumulates in the liver of a patient without a history of alcohol abuse. Nonalcoholic steatohepatitis (NASH), a severe form of NAFLD, can progress to liver cirrhosis and hepatocellular carcinoma. NAFLD is regarded as a hepatic manifestation of metabolic syndrome and incidence has been increasing worldwide in line with the increased prevalence of obesity, type 2 diabetes, and hyperlipemia. Animal models of NAFLD/NASH give crucial information, not only in elucidating pathogenesis of NAFLD/NASH but also in examining therapeutic effects of various agents. An ideal model of NAFLD/NASH should correctly reflect both hepatic histopathology and pathophysiology of human NAFLD/NASH. Animal models of NAFLD/NASH are divided into genetic, dietary, and combination models. In this paper, we review commonly used animal models of NAFLD/NASH referring to their advantages and disadvantages. (c) 2012 Baishideng. All rights reserved.
引用
收藏
页码:2300 / 2308
页数:9
相关论文
共 50 条
  • [41] Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Yoshihisa Takahashi
    Keiichiro Sugimoto
    Hiroshi Inui
    Toshio Fukusato
    World Journal of Gastroenterology, 2015, 21 (13) : 3777 - 3785
  • [42] The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Shouhed, Daniel
    Steggerda, Justin
    Burch, Miguel
    Noureddin, Mazen
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (09) : 797 - 811
  • [43] NONALCOHOLIC FATTY LIVER DISEASE AND STEATOHEPATITIS
    Colak, Yasar
    Tuncer, Ilyas
    JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2010, 73 (03): : 85 - 91
  • [44] Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammation
    Tilg, Herbert
    Moschen, Alexander
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2010, 13 (04) : 391 - 396
  • [45] Predictive Factors for Nonalcoholic Steatohepatitis (NASH) in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
    Fierbinteanu-Braticevici, Carmen
    Baicus, Cristian
    Tribus, Laura
    Papacocea, Raluca
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2011, 20 (02) : 153 - 159
  • [46] Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in HIV infection: a metabolic approach of an infectious disease
    Esteban Coronel-Castillo, Carlos
    Qi, Xingshun
    Contreras-Carmona, Jocelyn
    Lenin Ramirez-Perez, Oscar
    Mendez-Sanchez, Nahum
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (06) : 531 - 540
  • [47] Nonalcoholic Steatohepatitis Score is an Independent Predictor of Right Ventricular Dysfunction in Patients with Nonalcoholic Fatty Liver Disease
    Sunbul, Murat
    Kivrak, Tarik
    Durmus, Erdal
    Akin, Hakan
    Aydin, Yucel
    Ergelen, Rabia
    Yilmaz, Yusuf
    Agirbasli, Mehmet
    CARDIOVASCULAR THERAPEUTICS, 2015, 33 (05) : 294 - 299
  • [48] Animal Models of Fibrosis in Nonalcoholic Steatohepatitis: Do They Reflect Human Disease
    Ipsen, David H.
    Lykkesfeldt, Jens
    Tveden-Nyborg, Pernille
    ADVANCES IN NUTRITION, 2020, 11 (06) : 1696 - 1711
  • [49] Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Selected Practical Issues in Their Evaluation and Management
    Vuppalanchi, Raj
    Chalasani, Naga
    HEPATOLOGY, 2009, 49 (01) : 306 - 317
  • [50] Risk Factors for the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Genetics
    Lim, Huei-Wen
    Bernstein, David E.
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 39 - +